150 related articles for article (PubMed ID: 38519280)
1. The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations.
Light A; Mayor N; Cullen E; Kirkham A; Padhani AR; Arya M; Bomers JGR; Dudderidge T; Ehdaie B; Freeman A; Guillaumier S; Hindley R; Lakhani A; Pendse D; Punwani S; Rastinehad AR; Rouvière O; Sanchez-Salas R; Schoots IG; Sokhi HK; Tam H; Tempany CM; Valerio M; Verma S; Villeirs G; van der Meulen J; Ahmed HU; Shah TT
Eur Urol; 2024 May; 85(5):466-482. PubMed ID: 38519280
[TBL] [Abstract][Full Text] [Related]
2. Prostate MRI based on PI-RADS version 2: how we review and report.
Steiger P; Thoeny HC
Cancer Imaging; 2016 Apr; 16():9. PubMed ID: 27067275
[TBL] [Abstract][Full Text] [Related]
3. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy.
Giganti F; Dickinson L; Orczyk C; Haider A; Freeman A; Emberton M; Allen C; Moore CM
Eur Urol Oncol; 2023 Dec; 6(6):629-634. PubMed ID: 37210343
[TBL] [Abstract][Full Text] [Related]
4. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy.
Panebianco V; Villeirs G; Weinreb JC; Turkbey BI; Margolis DJ; Richenberg J; Schoots IG; Moore CM; Futterer J; Macura KJ; Oto A; Bittencourt LK; Haider MA; Salomon G; Tempany CM; Padhani AR; Barentsz JO
Eur Urol Oncol; 2021 Dec; 4(6):868-876. PubMed ID: 33582104
[TBL] [Abstract][Full Text] [Related]
5. ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.
de Rooij M; Israël B; Tummers M; Ahmed HU; Barrett T; Giganti F; Hamm B; Løgager V; Padhani A; Panebianco V; Puech P; Richenberg J; Rouvière O; Salomon G; Schoots I; Veltman J; Villeirs G; Walz J; Barentsz JO
Eur Radiol; 2020 Oct; 30(10):5404-5416. PubMed ID: 32424596
[TBL] [Abstract][Full Text] [Related]
6. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force.
Moore CM; Giganti F; Albertsen P; Allen C; Bangma C; Briganti A; Carroll P; Haider M; Kasivisvanathan V; Kirkham A; Klotz L; Ouzzane A; Padhani AR; Panebianco V; Pinto P; Puech P; Rannikko A; Renard-Penna R; Touijer K; Turkbey B; van Poppel H; Valdagni R; Walz J; Schoots I
Eur Urol; 2017 Apr; 71(4):648-655. PubMed ID: 27349615
[TBL] [Abstract][Full Text] [Related]
7. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging and Targeted Biopsies Compared to Transperineal Mapping Biopsies Before Focal Ablation in Localised and Metastatic Recurrent Prostate Cancer After Radiotherapy.
Shah TT; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Grierson J; Miah H; Emara A; Haroon A; Latifoltojar A; Sidhu H; Clemente J; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra A; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU
Eur Urol; 2022 Jun; 81(6):598-605. PubMed ID: 35370021
[TBL] [Abstract][Full Text] [Related]
9. Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer.
Barret E; Turkbey B; Puech P; Durand M; Panebianco V; Fütterer JJ; Renard-Penna R; Rouvière O
World J Urol; 2019 Mar; 37(3):429-436. PubMed ID: 30003373
[TBL] [Abstract][Full Text] [Related]
10. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.
Muller BG; Fütterer JJ; Gupta RT; Katz A; Kirkham A; Kurhanewicz J; Moul JW; Pinto PA; Rastinehad AR; Robertson C; de la Rosette J; Sanchez-Salas R; Jones JS; Ukimura O; Verma S; Wijkstra H; Marberger M
BJU Int; 2014 Feb; 113(2):218-27. PubMed ID: 24215670
[TBL] [Abstract][Full Text] [Related]
11. Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Large Multicenter Cohort Study.
von Hardenberg J; Borkowetz A; Siegel F; Kornienko K; Westhoff N; Jordan TB; Hoffmann M; Drerup M; Lieb V; Taymoorian K; Schostak M; Ganzer R; Höfner T; Cash H; Bruendl J;
Eur Urol Focus; 2021 Sep; 7(5):1002-1010. PubMed ID: 33877047
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
Lim CS; Abreu-Gomez J; Carrion I; Schieda N
AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
[No Abstract] [Full Text] [Related]
13. The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
Light A; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Emara A; Haroon A; Latifoltojar A; Sidhu H; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra AV; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU; Shah TT
Eur Urol; 2024 Jan; 85(1):35-46. PubMed ID: 37778954
[TBL] [Abstract][Full Text] [Related]
14. PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer.
Englman C; Maffei D; Allen C; Kirkham A; Albertsen P; Kasivisvanathan V; Baroni RH; Briganti A; De Visschere P; Dickinson L; Gómez Rivas J; Haider MA; Kesch C; Loeb S; Macura KJ; Margolis D; Mitra AM; Padhani AR; Panebianco V; Pinto PA; Ploussard G; Puech P; Purysko AS; Radtke JP; Rannikko A; Rastinehad A; Renard-Penna R; Sanguedolce F; Schimmöller L; Schoots IG; Shariat SF; Schieda N; Tempany CM; Turkbey B; Valerio M; Villers A; Walz J; Barrett T; Giganti F; Moore CM
Eur Urol; 2024 Mar; ():. PubMed ID: 38556436
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer.
Chu CE; Cowan JE; Lonergan PE; Washington SL; Fasulo V; de la Calle CM; Shinohara K; Westphalen AC; Carroll PR
Eur Urol Oncol; 2022 Oct; 5(5):537-543. PubMed ID: 33483265
[TBL] [Abstract][Full Text] [Related]
16. [PI-RADS 2.0 for Prostate MRI].
Franiel T; Röthke M
Radiologe; 2017 Aug; 57(8):665-678. PubMed ID: 28721448
[TBL] [Abstract][Full Text] [Related]
17. PI-RADS Version 2 Category on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging Predicts Oncologic Outcomes in Gleason 3 + 4 Prostate Cancer on Biopsy.
Faiena I; Salmasi A; Mendhiratta N; Markovic D; Ahuja P; Hsu W; Elashoff DA; Raman SS; Reiter RE
J Urol; 2019 Jan; 201(1):91-97. PubMed ID: 30577397
[TBL] [Abstract][Full Text] [Related]
18. [PI-RADS classification: structured reporting for MRI of the prostate].
Röthke M; Blondin D; Schlemmer HP; Franiel T
Rofo; 2013 Mar; 185(3):253-61. PubMed ID: 23404430
[TBL] [Abstract][Full Text] [Related]
19. PI-RR: The Prostate Imaging for Recurrence Reporting System for MRI Assessment of Local Prostate Cancer Recurrence After Radiation Therapy or Radical Prostatectomy-A Review.
Abreu-Gomez J; Dias AB; Ghai S
AJR Am J Roentgenol; 2023 Jun; 220(6):852-861. PubMed ID: 36722763
[TBL] [Abstract][Full Text] [Related]
20. Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference.
Vargas HA; Hötker AM; Goldman DA; Moskowitz CS; Gondo T; Matsumoto K; Ehdaie B; Woo S; Fine SW; Reuter VE; Sala E; Hricak H
Eur Radiol; 2016 Jun; 26(6):1606-12. PubMed ID: 26396111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
